do-me/EUR-LEX huggingface dataset:
Case T-354/24: Judgment of the General Court of 24 September 2025 – Mowi Poland v Commission (Public health – Specific hygiene rules for food of animal origin – Regulation (EC) No 853/2004 – Point 3(e) of the Annex to Delegated Regulation (EU) 2024/1141 – Action for annulment – Locus standi – Interest in bringing proceedings – Admissibility – Concept of frozen product – Lack of consultation with EFSA – Article 13 of Regulation No 853/2004)
Date: 2025-09-24
Institutions: General Court
Subjects: European Food Safety Authority, animal product, food safety, frozen product, public health, right of action








C_202505838EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5838


10.11.2025






Judgment of the General Court of 24 September 2025 – Mowi Poland v Commission


(Case T-354/24)
                (1)

(Public health - Specific hygiene rules for food of animal origin - Regulation (EC) No 853/2004 - Point 3(e) of the Annex to Delegated Regulation (EU) 2024/1141 - Action for annulment - Locus standi - Interest in bringing proceedings - Admissibility - Concept of ‘frozen product’ - Lack of consultation with EFSA - Article 13 of Regulation No 853/2004)
(C/2025/5838)
Language of the case: Polish

Parties


Applicant: Mowi Poland S.A. (Ustka, Poland) (represented by: Z. Kiedacz and K. Puchalska, lawyers)

Defendant: European Commission (represented by: M. Owsiany-Hornung, acting as Agent)

Intervener in support of the defendant: French Republic (represented by: B. Fodda, B. Travard and P. Chansou, acting as Agents)

Re:

By its action under Article 263 TFEU, the applicant seeks, in essence, the annulment of point 3(e) of the Annex to Commission Delegated Regulation (EU) 2024/1141 of 14 December 2023 amending Annexes II and III to Regulation (EC) No 853/2004 of the European Parliament and of the Council as regards specific hygiene requirements for certain meat, fishery products, dairy products and eggs (OJ L 2024/1141).

Operative part of the judgment

The Court:






1.


Annuls point 3(e) of the Annex to Commission Delegated Regulation (EU) 2024/1141 of 14 December 2023 amending Annexes II and III to Regulation (EC) No 853/2004 of the European Parliament and of the Council as regards specific hygiene requirements for certain meat, fishery products, dairy products and eggs;










2.


Orders the European Commission to bear its own costs and to pay those incurred by Mowi Poland S.A.;










3.


Orders the French Republic to bear its own costs.






(1)  
            OJ C, C/2024/5119, 26.8.2024.


ELI: http://data.europa.eu/eli/C/2025/5838/oj
ISSN 1977-091X (electronic edition)
Case T-33/25: Judgment of the General Court of 24 September 2025 – Quality First v EUIPO (CRAVE NO MORE) (EU trade mark – Application for the EU figurative mark CRAVE NO MORE – Absolute ground for refusal – No distinctive character – Article 7(1)(b) of Regulation (EU) 2017/1001)
Date: 2025-09-24
Institutions: General Court
Subjects: EU trade mark, dietary product, food supplement, registered trade mark, trade-mark law








C_202505847EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5847


10.11.2025






Judgment of the General Court of 24 September 2025 – Quality First v EUIPO (CRAVE NO MORE)


(Case T-33/25)
                (1)

(EU trade mark - Application for the EU figurative mark CRAVE NO MORE - Absolute ground for refusal - No distinctive character - Article 7(1)(b) of Regulation (EU) 2017/1001)
(C/2025/5847)
Language of the case: German

Parties


Applicant: Quality First GmbH (Elmshorn, Germany) (represented by: J. Schneider and M. Kleinn, lawyers)

Defendant: European Union Intellectual Property Office (represented by: E. Lobotková and D. Hanf, acting as Agents)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment and alteration of the decision of the Fifth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 21 November 2024 (Case R 793/2024-5).

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Quality First GmbH and the European Union Intellectual Property Office (EUIPO) each to bear their own costs.






(1)  
            OJ C, C/2025/1449, 10.3.2025.


ELI: http://data.europa.eu/eli/C/2025/5847/oj
ISSN 1977-091X (electronic edition)
Case T-415/24: Judgment of the General Court of 24 September 2025 – Cham Wings Airlines v Council (Common foreign and security policy – Restrictive measures taken in view of the situation in Syria – Freezing of funds – Lists of persons, entities and bodies subject to the freezing of funds and economic resources – Maintenance of the applicant’s name on the lists – Concept of association with the Syrian regime – Error of assessment – Obligation to state reasons – Proportionality)
Date: 2025-09-24
Institutions: General Court
Subjects: EU restrictive measure, Syria, airline, economic sanctions, freezing of assets, international sanctions, legal person, principle of proportionality








C_202505842EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5842


10.11.2025






Judgment of the General Court of 24 September 2025 – Cham Wings Airlines v Council


(Case T-415/24)
                (1)

(Common foreign and security policy - Restrictive measures taken in view of the situation in Syria - Freezing of funds - Lists of persons, entities and bodies subject to the freezing of funds and economic resources - Maintenance of the applicant’s name on the lists - Concept of ‘association with the Syrian regime’ - Error of assessment - Obligation to state reasons - Proportionality)
(C/2025/5842)
Language of the case: English

Parties


Applicant: Cham Wings Airlines LLC (Damascus, Syria) (represented by: L. Cloquet, lawyer)

Defendant: Council of the European Union (represented by: E. Kübler and P. Mahnič, acting as Agents)

Re:

By its action under Article 263 TFEU, the applicant seeks annulment of Council Decision (CFSP) 2024/1510 of 27 May 2024 amending Decision 2013/255/CFSP concerning restrictive measures in view of the situation in Syria (OJ L, 2024/1510) and Council Implementing Regulation (EU) 2024/1517 of 27 May 2024 implementing Regulation (EU) No 36/2012 concerning restrictive measures in view of the situation in Syria (OJ L, 2024/1517), in so far as those acts concern it.

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Cham Wings Airlines LLC to pay the costs.






(1)  
            OJ C, C/2024/5834, 7.10.2024.


ELI: http://data.europa.eu/eli/C/2025/5842/oj
ISSN 1977-091X (electronic edition)
Case T-258/23: Judgment of the General Court of 24 September 2025 – Zakłady Farmaceutyczne Polpharma v Commission (Medicinal products for human use – Variation of the marketing authorisation for Tecfidera – Dimethyl fumarate, a medicinal product for human use – Directive 2001/83/EC – Article 14(11) of Regulation (EC) No 726/2004 – Article 266 TFEU)
Date: 2025-09-24
Institutions: General Court
Subjects: disease of the nervous system, drug surveillance, market approval, medicinal product








C_202505820EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5820


10.11.2025






Judgment of the General Court of 24 September 2025 – Zakłady Farmaceutyczne Polpharma v Commission


(Case T-258/23)
                (1)

(Medicinal products for human use - Variation of the marketing authorisation for Tecfidera - Dimethyl fumarate, a medicinal product for human use - Directive 2001/83/EC - Article 14(11) of Regulation (EC) No 726/2004 - Article 266 TFEU)
(C/2025/5820)
Language of the case: English

Parties


Applicant: Zakłady Farmaceutyczne Polpharma S.A. (Starogard Gdański, Poland) (represented by: K. Roox, T. De Meese, J. Stuyck and C. Dumont, lawyers)

Defendant: European Commission (represented by: L. Haasbeek, E. Mathieu and A. Spina, acting as Agents)

Intervener in support of the applicant: Biogaran (Colombes, France) (represented by: C. Mereu and S. Englebert, lawyers)

Intervener in support of the defendant: Biogen Netherlands BV (Amsterdam, Netherlands) (represented by: C. Schoonderbeek and B. Jong, lawyers)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of Commission Implementing Decision C(2023) 3067 (final) of 2 May 2023 amending the marketing authorisation granted by Decision C(2014) 601 (final) for ‘Tecfidera – Dimethyl fumarate’, a medicinal product for human use.

Operative part of the judgment

The Court:






1.


Annuls Commission Implementing Decision C(2023) 3067 (final) of 2 May 2023 amending the marketing authorisation granted by Decision C(2014) 601 (final) for ‘Tecfidera – Dimethyl fumarate’, a medicinal product for human use;










2.


Dismisses the action as to the remainder;










3.


Orders the European Commission, in addition to bearing its own costs, to pay the costs incurred by Zakłady Farmaceutyczne Polpharma S.A., including those relating to the interim proceedings before the Court;










4.


Declares that Biogen Netherlands BV and Biogaran are to bear their own costs.






(1)  
            OJ C 252, 17.7.2023.


ELI: http://data.europa.eu/eli/C/2025/5820/oj
ISSN 1977-091X (electronic edition)
Case T-406/24: Judgment of the General Court of 24 September 2025 – Manufaktur Jörg Geiger v EUIPO – Consorzio di Tutela della Denominazione di Origine Controllata Prosecco (PriSecco) (EU trade mark – Invalidity proceedings – EU word mark PriSecco – Earlier PDO Prosecco – Relative ground for invalidity – Article 8(4) and Article 53(1)(c) of Regulation (EC) No 207/2009 – Article 103(2)(b) of Regulation (EU) No 1308/2013 – Concept of evocation of a PDO)
Date: 2025-09-24
Institutions: General Court
Subjects: EU trade mark, non-alcoholic beverage, registered trade mark, trade-mark law








C_202505839EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5839


10.11.2025






Judgment of the General Court of 24 September 2025 – Manufaktur Jörg Geiger v EUIPO – Consorzio di Tutela della Denominazione di Origine Controllata ‘Prosecco’ (PriSecco)


(Case T-406/24)
                (1)

(EU trade mark - Invalidity proceedings - EU word mark PriSecco - Earlier PDO ‘Prosecco’ - Relative ground for invalidity - Article 8(4) and Article 53(1)(c) of Regulation (EC) No 207/2009 - Article 103(2)(b) of Regulation (EU) No 1308/2013 - Concept of ‘evocation’ of a PDO)
(C/2025/5839)
Language of the case: English

Parties


Applicant: Manufaktur Jörg Geiger GmbH (Schlat, Germany) (represented by: W. Heisrath, F. Dehn and C. Kleiner, lawyers)

Defendant: European Union Intellectual Property Office (represented by: D. Gája, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Consorzio di Tutela della Denominazione di Origine Controllata ‘Prosecco’ (Treviso, Italy) (represented by: M. Mostardini, G. Galimberti, R. Tardiolo, C. Andreotta and F. Fili, lawyers)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment and, in essence, the alteration of the decision of the Fifth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 30 May 2024 (Case R 1454/2022-5).

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Manufaktur Jörg Geiger GmbH to bear its own costs and to pay those incurred by Consorzio di Tutela della Denominazione di Origine Controllata ‘Prosecco’;










3.


Orders the European Union Intellectual Property Office (EUIPO) to bear its own costs.






(1)  
            OJ C, C/2024/5430, 16.9.2024.


ELI: http://data.europa.eu/eli/C/2025/5839/oj
ISSN 1977-091X (electronic edition)
Case T-309/23: Judgment of the General Court of 24 September 2025 – Aliud Pharma v Commission (Medicinal products for human use – Variation of the marketing authorisation Tecfidera – Dimethyl fumarate, a medicinal product for human use – Directive 2001/83/EC – Article 14(11) of Regulation (EC) No 726/2004 – Article 266 TFEU)
Date: 2025-09-24
Institutions: General Court
Subjects: disease of the nervous system, drug surveillance, market approval, medicinal product








C_202505823EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5823


10.11.2025






Judgment of the General Court of 24 September 2025 – Aliud Pharma v Commission


(Case T-309/23)
                (1)

(Medicinal products for human use - Variation of the marketing authorisation Tecfidera - Dimethyl fumarate, a medicinal product for human use - Directive 2001/83/EC - Article 14(11) of Regulation (EC) No 726/2004 - Article 266 TFEU)
(C/2025/5823)
Language of the case: German

Parties


Applicant: Aliud Pharma GmbH (Laichingen, Germany) (represented by: P. von Czettritz, lawyer)

Defendant: European Commission (represented by: E. Mathieu, M. Noll-Ehlers and A. Spina, acting as Agents)

Intervener in support of the defendant: Biogen Netherlands BV (Amsterdam, Netherlands) (represented by: C. Schoonderbeek and B. Jong, lawyers)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of Commission Implementing Decision C(2023) 3067 final of 2 May 2023 amending the marketing authorisation granted by Implementing Decision C(2014) 601 final for the medicinal product for human use Tecfidera – Dimethyl fumarate.

Operative part of the judgment

The Court:






1.


Annuls Commission Implementing Decision C(2023) 3067 final of 2 May 2023, amending the marketing authorisation granted by Implementing Decision C(2014) 601 final for the medicinal product for human use Tecfidera – Dimethyl fumarate;










2.


Orders the European Commission to bear its own costs and pay those incurred by Aliud Pharma GmbH;










3.


Orders Netherlands BV to bear its own costs.






(1)  
            OJ C 261, 24.7.2023.


ELI: http://data.europa.eu/eli/C/2025/5823/oj
ISSN 1977-091X (electronic edition)
Case T-555/24: Judgment of the General Court of 24 September 2025 – Bioalchemilla and Alkemilla Eco Bio Cosmetic v EUIPO – Morale (NAMALEI) (EU trade mark – Invalidity proceedings – EU figurative mark NAMALEI – Absolute ground for invalidity – Absence of bad faith – Article 59(1)(b) of Regulation (EU) 2017/1001)
Date: 2025-09-24
Institutions: General Court
Subjects: EU trade mark, cosmetic product, dietary product, essential oil, food supplement, hairdressing and beauty care, registered trade mark, trade-mark law








C_202505844EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5844


10.11.2025






Judgment of the General Court of 24 September 2025 – Bioalchemilla and Alkemilla Eco Bio Cosmetic v EUIPO – Morale (NAMALEI)


(Case T-555/24)
                (1)

(EU trade mark - Invalidity proceedings - EU figurative mark NAMALEI - Absolute ground for invalidity - Absence of bad faith - Article 59(1)(b) of Regulation (EU) 2017/1001)
(C/2025/5844)
Language of the case: Italian

Parties


Applicants: Bioalchemilla Srl (Massafra, Italy), Alkemilla Eco Bio Cosmetic Srl (Massafra) (represented by: C. Pulpito, lawyer)

Defendant: European Union Intellectual Property Office (represented by: R. Raponi, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO: Paolo Morale (Massafra, Italy) (represented by: E. Pepe and S. Troilo, lawyers)

Re:

By their action under Article 263 TFEU, the applicants seek the annulment of the decision of the Fifth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 2 September 2024 (Case R 535/2023-5).

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Bioalchemilla Srl and Alkemilla Eco Bio Cosmetic Srl to each bear their own costs and pay those incurred by Mr Paolo Morale for the purposes of the proceedings before the Court;










3.


Orders the European Union Intellectual Property Office (EUIPO) to bear its own costs.






(1)  
            OJ C, C/2025/89, 6.1.2025.


ELI: http://data.europa.eu/eli/C/2025/5844/oj
ISSN 1977-091X (electronic edition)
Non-opposition to a notified concentration (Case M.12064 – STRABAG / WTE)
Date: 2025-09-24
Institutions: Directorate-General for Competition, European Commission
Subjects: building industry, civil engineering, economic concentration, merger control, public sanitation, sewage sludge, waste recycling, wastewater, water supply, water treatment








C_202505387EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5387


2.10.2025






Non-opposition to a notified concentration
(Case M.12064 – STRABAG / WTE)
(Text with EEA relevance)
(C/2025/5387)

On 24 September 2025, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the ‘Competition policy’ website of the Commission (https://competition-cases.ec.europa.eu/search). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32025M12064. EUR-Lex is the online point of access to European Union law.






(1)  
            OJ L 24, 29.1.2004, p. 1.


ELI: http://data.europa.eu/eli/C/2025/5387/oj
ISSN 1977-091X (electronic edition)
Case T-1083/23: Judgment of the General Court of 24 September 2025 – XH v Commission (Civil service – Officials – Investigation conducted by OLAF – Transfer for the duration of the investigation – Article 7(1) of the Staff Regulations – Request for assistance – Request for the use of documents under Article 19 of the Staff Regulations – Action for annulment – Act not open to challenge – Preparatory measure – Failure to follow the pre-litigation procedure – Partial inadmissibility – Interests of the service – Equivalence of posts – Liability)
Date: 2025-09-24
Institutions: General Court
Subjects: European Anti-fraud Office, European official, confidentiality, damages, disciplinary proceedings, staff regulations (EU)








C_202505828EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5828


10.11.2025






Judgment of the General Court of 24 September 2025 – XH v Commission


(Case T-1083/23)
                (1)

(Civil service - Officials - Investigation conducted by OLAF - Transfer for the duration of the investigation - Article 7(1) of the Staff Regulations - Request for assistance - Request for the use of documents under Article 19 of the Staff Regulations - Action for annulment - Act not open to challenge - Preparatory measure - Failure to follow the pre-litigation procedure - Partial inadmissibility - Interests of the service - Equivalence of posts - Liability)
(C/2025/5828)
Language of the case: English

Parties


Applicant: XH (represented by: M. Stanek, lawyer)

Defendant: European Commission (represented by: J.-F. Brakeland, L. Hohenecker and M. Brauhoff, acting as Agents)

Re:

By its action under Article 270 TFEU, the applicant seeks, in essence, first, the annulment (i) of the decision of the European Anti-Fraud Office (OLAF) of 24 March 2023, by which she was transferred on a provisional basis from a first unit to a second unit given the ongoing internal investigation bearing the reference OC/2022/0394/A1 in which she was one of the persons implicated, as is confirmed by the decision of the Director-General of OLAF of 17 October 2023 rejecting her complaint, (ii) of the decision of the Director-General of OLAF of 17 October 2023 rejecting her request concerning the alleged irregularities vitiating investigation OC/2022/0394/A1, (iii) of the decision of the Director-General of OLAF of 17 October 2023 refusing her request for assistance and (iv) of the decision of the Director-General of OLAF of 17 October 2023 rejecting her request for permission to use the documents annexed to her complaint in legal proceedings before courts outside of the European Union, and, secondly, compensation for the damage she allegedly suffered as a result.

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders XH to pay the costs.






(1)  
            OJ C, C/2024/3780, 24.6.2024.


ELI: http://data.europa.eu/eli/C/2025/5828/oj
ISSN 1977-091X (electronic edition)
Case T-299/23: Judgment of the General Court of 24 September 2025 – Hexal v Commission (Medicinal products for human use – Variation of the marketing authorisation for the medicinal product for human use Tecfidera – dimethyl fumarate – Directive 2001/83/EC – Article 14(11) of Regulation (EC) No 726/2004 – Article 266 TFEU)
Date: 2025-09-24
Institutions: General Court
Subjects: disease of the nervous system, drug surveillance, market approval, medicinal product








C_202505822EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5822


10.11.2025






Judgment of the General Court of 24 September 2025 – Hexal v Commission


(Case T-299/23)
                (1)

(Medicinal products for human use - Variation of the marketing authorisation for the medicinal product for human use Tecfidera - dimethyl fumarate - Directive 2001/83/EC - Article 14(11) of Regulation (EC) No 726/2004 - Article 266 TFEU)
(C/2025/5822)
Language of the case: German

Parties


Applicant: Hexal AG (Holzkirchen, Germany) (represented by: P. von Czettritz, lawyer)

Defendant: European Commission (represented by: E. Mathieu, M. Noll-Ehlers and A. Spina, acting as Agents)

Intervener in support of the defendant: Biogen Netherlands BV (Amsterdam, Netherlands) (represented by: C. Schoonderbeek and B. Jong, lawyers)

Subject

By its action under Article 263 TFEU, the applicant seeks annulment of Commission Implementing Decision C(2023) 3067 final of 2 May 2023 amending the marketing authorisation granted by Implementing Decision C(2014) 601 final for the medicinal product for human use Tecfidera – dimethyl fumarate.

Operative part of the judgment

The Court:






1.


Annuls Commission Implementing Decision C(2023) 3067 final of 2 May 2023 amending the marketing authorisation granted by Implementing Decision C(2014) 601 final for the medicinal product for human use Tecfidera – dimethyl fumarate;










2.


Orders the European Commission to bear its own costs and to pay those incurred by Hexal AG;










3.


Orders Biogen Netherlands BV to bear its own costs.






(1)  
            OJ C 261 of 24.7.2023.


ELI: http://data.europa.eu/eli/C/2025/5822/oj
ISSN 1977-091X (electronic edition)